Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Linker for activation of T-cells (LAT) is a critical integral membrane adaptor protein primarily expressed in T-cells, NK cells, and mast cells. It lacks intrinsic enzymatic activity but serves as a fundamental signaling hub by organizing the 'LAT signalosome' upon phosphorylation by the kinase ZAP-70 following T-cell receptor activation (UniProt: P43441). By recruiting various effector proteins, LAT facilitates the transmission of signals from the cell surface to the nucleus, driving T-cell differentiation, proliferation, and cytokine production (PubMed: 25173748). Due to its central role in immune response, LAT is a significant target for investigating T-cell-mediated pathologies, including autoimmune disorders and certain T-cell malignancies. Genetic mutations or dysregulation of LAT are associated with severe combined immunodeficiency and systemic lupus erythematosus, highlighting its importance in maintaining immune homeostasis (PubMed: 28834471). While direct pharmacological targeting of LAT remains largely in the experimental and preclinical stages, it is considered a high-value node for the development of immunomodulatory therapies designed to fine-tune T-cell sensitivity or disrupt aberrant signaling in allergic and inflammatory diseases (NCBI: PMC4021319).
Functions as a central scaffold protein that is phosphorylated by ZAP-70 following T-cell receptor (TCR) stimulation; once phosphorylated, it recruits SH2-domain-containing proteins such as PLC-gamma-1, Grb2, and Gads to initiate downstream signaling cascades including the Ras/MAPK and calcium pathways.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Linker for activation of T-cells (LAT) (LAT).